Enleofen Bio

Enleofen Bio Pte Ltd. is developing novel anti-fibrotic therapies based on breakthrough science. Enleofen aims to use its antibody in clinical trials within two years, with the goal of developing a drug that can be used to treat a variety of diseases for which there are currently no treatment options.